BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24705863)

  • 1. Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.
    Xiao WZ; Han DH; Wang F; Wang YQ; Zhu YH; Wu YF; Liu NT; Sun JY
    Tumour Biol; 2014 Jul; 35(7):6687-93. PubMed ID: 24705863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter regarding Xiao WZ et al. entitled "Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis".
    Dai W; Chen J; Guo X; Su Z
    Tumour Biol; 2015 Jun; 36(6):4089. PubMed ID: 26025112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis.
    Han F; Hu R; Yang H; Liu J; Sui J; Xiang X; Wang F; Chu L; Song S
    Onco Targets Ther; 2016; 9():3485-92. PubMed ID: 27366085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between abnormal MMP2 expression and prognosis in gastric cancer: a meta-analysis of cohort studies.
    Wang HL; Zhou PY; Zhang Y; Liu P
    Cancer Biother Radiopharm; 2014 May; 29(4):166-72. PubMed ID: 24784911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased osteopontin protein expression may be correlated with poor prognosis in non-small-cell lung cancer: A meta analysis.
    Shi SM; Su ZB; Zhao JJ; Yu DJ; Tu JW; Zhu JQ; Zhao JP; Sheng L; Wang SB; Sheng YJ; Chen HJ; Tian JH; Zhang Y; Wang J
    J Cancer Res Ther; 2016; 12(1):277-82. PubMed ID: 27072251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia.
    Abdullah JM; Farizan A; Asmarina K; Zainuddin N; Ghazali MM; Jaafar H; Isa MN; Naing NN
    Asian J Surg; 2006 Oct; 29(4):274-82. PubMed ID: 17098662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Expression of PTEN is Associated with Worse Prognosis in Patients with Cancer.
    Qiu ZX; Zhao S; Li L; Li WM
    Asian Pac J Cancer Prev; 2015; 16(11):4691-8. PubMed ID: 26107225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
    Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
    BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
    Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y
    Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal PTEN as a Predictive Marker of Aggressive Gliomas.
    Patnam S; Samal R; Koyyada R; Joshi P; Singh AD; Nagalla B; Soma MR; Sannareddy RR; Ippili K; Raju S; Boola RG; Lath R; Ranjan A; Ghosh S; Balamurugan M; Ray A; Manda SV
    Neurol India; 2022; 70(1):215-222. PubMed ID: 35263886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate.
    Yang Y; Shao N; Luo G; Li L; Zheng L; Nilsson-Ehle P; Xu N
    Anticancer Res; 2010 Mar; 30(3):981-5. PubMed ID: 20393024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
    Vuong HG; Altibi AMA; Duong UNP; Ngo HTT; Pham TQ; Chan AK; Park CK; Fung KM; Hassell L
    Crit Rev Oncol Hematol; 2017 Dec; 120():1-9. PubMed ID: 29198322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis.
    Kai Z; Dingyang L; Zhuanyi Y
    World Neurosurg; 2021 Mar; 147():42-46. PubMed ID: 33316486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TERT Genetic Mutations as Prognostic Marker in Glioma.
    Geng P; Zhao X; Ou J; Li J; Sa R; Liang H
    Mol Neurobiol; 2017 Jul; 54(5):3665-3669. PubMed ID: 27206431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis.
    Lv D; Lu L; Hu Z; Fei Z; Liu M; Wei L; Xu J
    Mol Neurobiol; 2017 Jan; 54(1):727-735. PubMed ID: 26768429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: a meta-analysis.
    Wang ZM; Liu J; Liu HB; Ye M; Zhang YF; Yang DS
    Biomed Res Int; 2014; 2014():364207. PubMed ID: 25028647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal vascular endothelial growth factor protein expression may be correlated with poor prognosis in diffuse large B-cell lymphoma: A meta-analysis.
    Jiang L; Sun JH; Quan LN; Tian YY; Jia CM; Liu ZQ; Liu AC
    J Cancer Res Ther; 2016; 12(2):605-11. PubMed ID: 27461618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between VEGF protein expression and pathological characteristics of diffuse large B cell lymphoma: a meta-analysis.
    Sui L; Liu K; Shen W; Zhang L
    Tumour Biol; 2014 Sep; 35(9):9085-93. PubMed ID: 24913710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant promoter methylation of the vimentin gene may contribute to colorectal carcinogenesis: a meta-analysis.
    Li YW; Kong FM; Zhou JP; Dong M
    Tumour Biol; 2014 Jul; 35(7):6783-90. PubMed ID: 24729088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of PGR genetic polymorphisms to the pathogenesis of endometrial cancer: A meta-analysis.
    Chen Z; Wang SH; Zhou J; Wu T; Li J
    J Cancer Res Ther; 2015; 11(4):810-7. PubMed ID: 26881523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.